Birdwatch Note
2024-10-21 11:41:57 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
特例承認は、緊急承認と違い、海外で流通していることを前提とした制度です https://www.mhlw.go.jp/content/11121000/001036029.pdf つまり、何処かの国で承認のための適正な治験が行われていることが前提なので、「治験をすっ飛ばして承認」する制度ではありません。 新型コロナワクチンは米国で正式に承認されています https://www.bbc.com/japanese/58314498 https://www.nikkei.com/article/DGXZQOGN23B5X0T20C21A8000000/ https://www.jetro.go.jp/biznews/2022/02/1622688660cbfd11.html https://assets.modernatx.com/m/6c1531aae2528bfb/original/20220131_----FDA.pdf トランプ元大統領下のワープスピード計画は、政府の財政支援により複数の過程を同時進行させるなどして治験の高速化を図ったものであり、証明過程を省略したわけではありません https://txbiz.tv-tokyo.co.jp/nms/market/post_229083 https://www.natureasia.com/ja-jp/ndigest/v18/n3/COVID%E3%83%AF%E3%82%AF%E3%83%81%E3%83%B3%E3%81%AE%E7%9F%AD%E6%9C%9F%E9%96%8B%E7%99%BA%E3%81%8C%E4%BB%8A%E5%BE%8C%E3%81%AE%E3%83%AF%E3%82%AF%E3%83%81%E3%83%B3%E9%96%8B%E7%99%BA%E3%81%AB%E3%82%82%E3%81%9F%E3%82%89%E3%81%99%E3%82%82%E3%81%AE/106649 「海外でやめてる」はOur World in Dataの登録が途中から止まっていることから生まれたデマです https://ourworldindata.org/explorers/coronavirus-data-explorer?zoomToSelection=true&time=2020-03-01..latest&facet=none&country=GBR~CAN~JPN~England~USA~KOR~CHN~TUR~MEX~GIB~Wales~Northern+Ireland~GGY~TWN~BEL~HKG~SWE~PER~MLT~URY~ARG~BTN~ITA&pickerSort=asc&pickerMetric=location&Metric=Vaccine+booster+doses&Interval=7-day+rolling+average&Relative+to+Population=true&Color+by+test+positivity=false
Written by EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1848230129836957936
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1848328869230858265
- noteId - 1848328869230858265
- participantId -
- noteAuthorParticipantId - EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00 Participant Details
- createdAtMillis - 1729510917371
- tweetId - 1848230129836957936
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 特例承認は、緊急承認と違い、海外で流通していることを前提とした制度です https://www.mhlw.go.jp/content/11121000/001036029.pdf つまり、何処かの国で承認のための適正な治験が行われていることが前提なので、「治験をすっ飛ばして承認」する制度ではありません。 新型コロナワクチンは米国で正式に承認されています https://www.bbc.com/japanese/58314498 https://www.nikkei.com/article/DGXZQOGN23B5X0T20C21A8000000/ https://www.jetro.go.jp/biznews/2022/02/1622688660cbfd11.html https://assets.modernatx.com/m/6c1531aae2528bfb/original/20220131_----FDA.pdf トランプ元大統領下のワープスピード計画は、政府の財政支援により複数の過程を同時進行させるなどして治験の高速化を図ったものであり、証明過程を省略したわけではありません https://txbiz.tv-tokyo.co.jp/nms/market/post_229083 https://www.natureasia.com/ja-jp/ndigest/v18/n3/COVID%E3%83%AF%E3%82%AF%E3%83%81%E3%83%B3%E3%81%AE%E7%9F%AD%E6%9C%9F%E9%96%8B%E7%99%BA%E3%81%8C%E4%BB%8A%E5%BE%8C%E3%81%AE%E3%83%AF%E3%82%AF%E3%83%81%E3%83%B3%E9%96%8B%E7%99%BA%E3%81%AB%E3%82%82%E3%81%9F%E3%82%89%E3%81%99%E3%82%82%E3%81%AE/106649 「海外でやめてる」はOur World in Dataの登録が途中から止まっていることから生まれたデマです https://ourworldindata.org/explorers/coronavirus-data-explorer?zoomToSelection=true&time=2020-03-01..latest&facet=none&country=GBR~CAN~JPN~England~USA~KOR~CHN~TUR~MEX~GIB~Wales~Northern+Ireland~GGY~TWN~BEL~HKG~SWE~PER~MLT~URY~ARG~BTN~ITA&pickerSort=asc&pickerMetric=location&Metric=Vaccine+booster+doses&Interval=7-day+rolling+average&Relative+to+Population=true&Color+by+test+positivity=false
Note Ratings
rated at | rated by | |
2024-10-22 20:50:05 -0500 | Rating Details | |
2024-10-21 21:33:11 -0500 | Rating Details | |
2024-10-21 19:27:17 -0500 | Rating Details | |
2024-10-21 11:47:36 -0500 | Rating Details | |
2024-10-21 10:10:13 -0500 | Rating Details | |
2024-10-21 09:31:26 -0500 | Rating Details | |
2024-10-21 09:09:23 -0500 | Rating Details | |
2024-10-21 08:49:10 -0500 | Rating Details | |
2024-10-21 08:07:59 -0500 | Rating Details | |
2024-10-21 08:06:55 -0500 | Rating Details | |
2024-10-21 08:00:24 -0500 | Rating Details | |
2024-10-21 07:51:11 -0500 | Rating Details | |
2024-10-21 07:47:01 -0500 | Rating Details | |
2024-10-21 07:43:00 -0500 | Rating Details | |
2024-10-21 07:37:37 -0500 | Rating Details | |
2024-10-21 07:14:30 -0500 | Rating Details | |
2024-10-21 07:09:56 -0500 | Rating Details | |
2024-10-21 06:56:54 -0500 | Rating Details | |
2024-10-27 04:07:09 -0500 | Rating Details | |
2024-10-23 06:41:05 -0500 | Rating Details | |
2024-10-21 16:25:43 -0500 | Rating Details | |
2024-10-21 10:21:27 -0500 | Rating Details | |
2024-10-21 09:48:23 -0500 | Rating Details | |
2024-10-21 09:34:51 -0500 | Rating Details | |
2024-10-21 09:14:52 -0500 | Rating Details | |
2024-10-21 08:09:33 -0500 | Rating Details | |
2024-10-21 07:53:17 -0500 | Rating Details | |
2024-10-21 07:41:10 -0500 | Rating Details | |
2024-10-21 07:40:39 -0500 | Rating Details | |
2024-10-21 23:15:51 -0500 | Rating Details | |
2024-10-21 12:36:39 -0500 | Rating Details | |
2024-10-21 12:10:21 -0500 | Rating Details | |
2024-10-21 11:26:46 -0500 | Rating Details | |
2024-10-21 09:40:40 -0500 | Rating Details | |
2024-10-21 09:37:25 -0500 | Rating Details | |
2024-10-21 09:31:27 -0500 | Rating Details | |
2024-10-21 08:50:31 -0500 | Rating Details | |
2024-10-21 08:37:28 -0500 | Rating Details | |
2024-10-21 08:14:23 -0500 | Rating Details | |
2024-10-21 07:33:19 -0500 | Rating Details | |
2024-10-21 06:48:32 -0500 | Rating Details | |
2024-10-26 12:41:18 -0500 | Rating Details | |
2024-10-24 23:22:05 -0500 | Rating Details | |
2024-10-22 20:07:12 -0500 | Rating Details | |
2024-10-22 00:43:09 -0500 | Rating Details | |
2024-10-21 21:05:12 -0500 | Rating Details | |
2024-10-21 18:27:32 -0500 | Rating Details | |
2024-10-21 15:28:53 -0500 | Rating Details | |
2024-10-21 13:46:29 -0500 | Rating Details | |
2024-10-21 13:07:20 -0500 | Rating Details | |
2024-10-21 12:32:21 -0500 | Rating Details | |
2024-10-21 11:43:03 -0500 | Rating Details | |
2024-10-21 09:40:08 -0500 | Rating Details | |
2024-10-21 08:54:44 -0500 | Rating Details | |
2024-10-21 08:22:21 -0500 | Rating Details | |
2024-10-21 08:07:39 -0500 | Rating Details | |
2024-10-21 07:53:42 -0500 | Rating Details | |
2024-10-21 07:44:22 -0500 | Rating Details | |
2024-10-21 07:32:53 -0500 | Rating Details | |
2024-10-21 07:08:32 -0500 | Rating Details | |
2024-10-21 07:04:31 -0500 | Rating Details | |
2024-10-21 06:52:25 -0500 | Rating Details | |
2024-10-21 06:49:50 -0500 | Rating Details | |
2024-10-27 04:18:38 -0500 | Rating Details | |
2024-10-22 04:27:25 -0500 | Rating Details | |
2024-10-22 03:30:14 -0500 | Rating Details | |
2024-10-21 21:30:27 -0500 | Rating Details | |
2024-10-21 21:19:50 -0500 | Rating Details | |
2024-10-21 19:38:09 -0500 | Rating Details | |
2024-10-21 17:11:08 -0500 | Rating Details | |
2024-10-21 16:06:27 -0500 | Rating Details | |
2024-10-21 14:59:16 -0500 | Rating Details | |
2024-10-21 11:14:05 -0500 | Rating Details | |
2024-10-21 10:12:24 -0500 | Rating Details | |
2024-10-21 08:48:31 -0500 | Rating Details | |
2024-10-21 08:48:30 -0500 | Rating Details | |
2024-10-21 08:40:56 -0500 | Rating Details | |
2024-10-21 07:49:50 -0500 | Rating Details | |
2024-10-21 07:40:39 -0500 | Rating Details | |
2024-10-21 07:33:56 -0500 | Rating Details | |
2024-10-21 07:23:48 -0500 | Rating Details | |
2024-10-21 07:04:53 -0500 | Rating Details | |
2025-02-21 16:40:27 -0600 | Rating Details |